[Current status of the activity of 5-HT3 receptor antagonists in animal pharmacology].
Most tests used for the screening of 5-HT3 receptor antagonists are not completely specific but they give satisfactory results when they are used in battery. In cancer chemotherapy and radiotherapy, 5-HT3 receptor antagonists are very active against acute emesis but delayed and anticipatory vomiting remains difficult to cure. Potential activities of 5-HT3 receptor antagonists as neuroleptics, anxiolytics and agents useful against dependence and cognitive disorders pose some problems in animal psychopharmacology and remain to be clinically validated.